Minimally invasive techniques (MIS) have evolved quickly in colorectal surgery during the last two decades. Transanal total mesorectal excision (taTME) was developed as a combination of skills taken from different MIS approaches, such as Transanal Endoscopic Microsurgery (TEM), Transanal Minimally Invasive Surgery (TAMIS) and Natural Orifices Transluminal Endoscopic Surgery (NOTES). TaTME allows for better visualization of the surgical planes of dissection and for the achievement of rectal resection following oncologic principles.

Since the first taTME resection assisted by laparoscopy was reported in 2010, taTME performed on patients with rectal cancer has showed promising results with regard to pathological quality, and short and midterm outcomes.

However, this new approach goes further, and is also used today in benign pathologies, offering multiple advantages in cases of inflammatory bowel disease and Hartmann reversal, especially in difficult patients, male patients, patients with narrow pelvises, and patients with multiple previous surgeries.

In this lecture, Borja de Lacy explains the advantages of the Transanal Colorectal Endoscopic Surgery, its indications, and the promising results obtained to date with this new technique.

Faculty keyboard_arrow_down

Dr. Borja de Lacy MD, PhD, General, Gastrointestinal and Oncologic Surgeon, Instituto Quirúrgico Lacy, Hospital Quironsalud Barcelona and Hospital Quironsalud Badalona, Surgical Coordinator Hospital Quironsalud Badalona, Spain General Surgery